OBJECTIVE: To report the incidence of lower urinary tract symptoms (LUTS) in a racially and ethnically and age-diverse U.S. population-based sample of men and women. MATERIALS AND METHODS: We conducted a prospective cohort study with 5 years of follow-up. A stratified 2-stage cluster random sampling method was used to recruit 5502 Boston residents aged 30-79 years of black, Hispanic, or white race or ethnicity. Of these, 4144 (1610 men and 2534 women) completed the follow-up protocol. The American Urological Association Symptom Index was used to define moderate-to-severe LUTS. RESULTS: Of the 3301 men and women with no or mild LUTS at baseline, the 5-year incidence of moderate-to-severe LUTS (American Urological Association Symptom Index ≥8) was 11.4% overall and was higher for women than for men (13.9% vs 8.5%, P = .02). Although the incidence increased with age (P <.001), it had a plateau among women aged 50-70 years and then doubled to 35.0% among women aged ≥70 years. White men had a distinctly lower incidence (7%) than all other sex and race subgroups (13%). CONCLUSION: Approximately 1 in 10 adults had newly developed LUTS at 5 years follow-up of in our study, with differences by sex and race or ethnicity, indicating a greater occurrence of urologic problems among black and Hispanic participants and women.
OBJECTIVE: To report the incidence of lower urinary tract symptoms (LUTS) in a racially and ethnically and age-diverse U.S. population-based sample of men and women. MATERIALS AND METHODS: We conducted a prospective cohort study with 5 years of follow-up. A stratified 2-stage cluster random sampling method was used to recruit 5502 Boston residents aged 30-79 years of black, Hispanic, or white race or ethnicity. Of these, 4144 (1610 men and 2534 women) completed the follow-up protocol. The American Urological Association Symptom Index was used to define moderate-to-severe LUTS. RESULTS: Of the 3301 men and women with no or mild LUTS at baseline, the 5-year incidence of moderate-to-severe LUTS (American Urological Association Symptom Index ≥8) was 11.4% overall and was higher for women than for men (13.9% vs 8.5%, P = .02). Although the incidence increased with age (P <.001), it had a plateau among women aged 50-70 years and then doubled to 35.0% among women aged ≥70 years. White men had a distinctly lower incidence (7%) than all other sex and race subgroups (13%). CONCLUSION: Approximately 1 in 10 adults had newly developed LUTS at 5 years follow-up of in our study, with differences by sex and race or ethnicity, indicating a greater occurrence of urologic problems among black and Hispanic participants and women.
Authors: Elizabeth A Platz; Corinne E Joshu; Alison M Mondul; Sarah B Peskoe; Walter C Willett; Edward Giovannucci Journal: J Urol Date: 2012-06-15 Impact factor: 7.450
Authors: Christian Temml; Clemens Brössner; Georg Schatzl; Anton Ponholzer; Leise Knoepp; Stephan Madersbacher Journal: Eur Urol Date: 2003-04 Impact factor: 20.096
Authors: Aruna V Sarma; Julie C McLaughlin; Steven J Jacobsen; John Logie; Paul Dolin; Rodney L Dunn; Kathleen A Cooney; James E Montie; David Schottenfeld; John T Wei Journal: Urology Date: 2004-11 Impact factor: 2.649
Authors: Maryellen S Kelly; Jonathan C Routh; Leah G Davis; J Todd Purves; John S Wiener; Matthew L Maciejewski Journal: Clin Pediatr (Phila) Date: 2018-08-27 Impact factor: 1.168
Authors: Beverly Rosa Williams; Keith Vargo; Diane K Newman; D Yvette Lacoursiere; Elizabeth R Mueller; John Connett; Lisa Kane Low; Aimee S James; Ariana L Smith; Kathryn H Schmitz; Kathryn L Burgio Journal: Urol Nurs Date: 2020 Nov-Dec
Authors: Arthur L Burnett; David R Walker; Qi Feng; Karissa M Johnston; Greta Lozano-Ortega; David Nimke; John C Hairston Journal: Neurourol Urodyn Date: 2020-05-08 Impact factor: 2.696